Should You Hold Kiromic Biopharma Inc Stock Monday - InvestorsObserver
| KRBPDelisted Stock | USD 2.68 0.07 2.55% |
Slightly above 62% of Kiromic Biopharma's investor base is looking to short. The analysis of overall sentiment of trading Kiromic Biopharma stock suggests that many investors are alarmed at this time. Kiromic Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Kiromic Biopharma. Many technical investors use Kiromic Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Kiromic |
Should You Hold Kiromic Biopharma Inc Stock Monday InvestorsObserver
Read at news.google.com
 |
Kiromic Biopharma Fundamental Analysis
We analyze Kiromic Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kiromic Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kiromic Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Kiromic Biopharma is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Kiromic Biopharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kiromic Biopharma stock to make a market-neutral strategy. Peer analysis of Kiromic Biopharma could also be used in its relative valuation, which is a method of valuing Kiromic Biopharma by comparing valuation metrics with similar companies.
Peers
Kiromic Biopharma Related Equities
| PALI | Palisade Bio | 49.29 | ||||
| UNCY | Unicycive Therapeutics | 9.59 | ||||
| RVPH | Reviva Pharmaceuticals | 5.56 | ||||
| CYTO | Altamira Therapeutics | 2.17 | ||||
| ENVB | Enveric Biosciences | 0.56 | ||||
| IMMX | Immix Biopharma | 0.86 | ||||
| ALLR | Allarity Therapeutics | 1.90 | ||||
| VRAX | Virax Biolabs | 2.35 | ||||
| CNSP | Cns Pharmaceuticals | 2.73 | ||||
| ZVSA | ZyVersa Therapeutics | 3.57 | ||||
| BDRX | Biodexa Pharmaceticals | 4.91 | ||||
| SONN | Sonnet Biotherapeutics | 5.24 | ||||
| QNRX | Quoin Pharmaceuticals | 6.05 | ||||
| ZURA | Zura Bio | 20.86 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |